Nevro Corp Stock Current Ratio
| NVRO Stock | USD 4.52 0.45 11.06% |
Nevro Corp fundamentals help investors to digest information that contributes to Nevro Corp's financial success or failures. It also enables traders to predict the movement of Nevro Stock. The fundamental analysis module provides a way to measure Nevro Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nevro Corp stock.
Nevro |
Nevro Corp Company Current Ratio Analysis
Nevro Corp's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Nevro Corp Current Ratio | 6.65 X |
Most of Nevro Corp's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nevro Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Nevro Corp has a Current Ratio of 6.65 times. This is 128.52% higher than that of the Health Care Equipment & Supplies sector and 95.59% higher than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
Nevro Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nevro Corp's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nevro Corp could also be used in its relative valuation, which is a method of valuing Nevro Corp by comparing valuation metrics of similar companies.Nevro Corp is currently under evaluation in current ratio category among its peers.
Nevro Fundamentals
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0902 | ||||
| Profit Margin | (0.17) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 159 M | ||||
| Shares Outstanding | 37.28 M | ||||
| Shares Owned By Insiders | 3.73 % | ||||
| Shares Owned By Institutions | 96.40 % | ||||
| Number Of Shares Shorted | 3.14 M | ||||
| Price To Earning | (63.38) X | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 0.47 X | ||||
| Revenue | 425.17 M | ||||
| Gross Profit | 276.37 M | ||||
| EBITDA | (87.77 M) | ||||
| Net Income | (92.21 M) | ||||
| Cash And Equivalents | 310.82 M | ||||
| Cash Per Share | 8.78 X | ||||
| Total Debt | 221.83 M | ||||
| Debt To Equity | 0.89 % | ||||
| Current Ratio | 6.65 X | ||||
| Book Value Per Share | 7.31 X | ||||
| Cash Flow From Operations | (64.66 M) | ||||
| Short Ratio | 9.16 X | ||||
| Earnings Per Share | (2.12) X | ||||
| Price To Earnings To Growth | (3.13) X | ||||
| Target Price | 9.79 | ||||
| Number Of Employees | 1.22 K | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 189.61 M | ||||
| Total Asset | 635.71 M | ||||
| Retained Earnings | (699.41 M) | ||||
| Working Capital | 447.55 M | ||||
| Current Asset | 282.63 M | ||||
| Current Liabilities | 36.39 M | ||||
| Net Asset | 635.71 M |
About Nevro Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nevro Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nevro Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nevro Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Nevro Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.Moving against Nevro Stock
| 0.51 | BSX | Boston Scientific Corp | PairCorr |
| 0.5 | VMD | Viemed Healthcare | PairCorr |
| 0.45 | VNRX | Volitionrx | PairCorr |
| 0.39 | LNSR | LENSAR Inc | PairCorr |
| 0.38 | CAH | Cardinal Health | PairCorr |
The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.
The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Nevro Corp Piotroski F Score and Nevro Corp Altman Z Score analysis. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.